Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.52
(
-0.13%
)
Bitcoin
73,758.24
(
-0.25%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: swampboots post# 89958

Tuesday, 02/02/2010 1:38:33 AM

Tuesday, February 02, 2010 1:38:33 AM

Post# of 257253

can you weigh in on Avastin for wet macular?

We should have hard data on this soon. The NIH is testing Lucentis vs Avastin in the CATT trial; according to clinicaltrails.gov, the one-year primary-endpoint data on visual acuity is expected this month:

http://clinicaltrials.gov/ct2/show/NCT00593450

So far nothing works even Lucentis...

I do not understand what you mean by this.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up